Imre Noth

16.1k total citations · 1 hit paper
143 papers, 6.1k citations indexed

About

Imre Noth is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Imre Noth has authored 143 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Pulmonary and Respiratory Medicine, 41 papers in Physiology and 19 papers in Epidemiology. Recurrent topics in Imre Noth's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (120 papers), Medical Imaging and Pathology Studies (29 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). Imre Noth is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (120 papers), Medical Imaging and Pathology Studies (29 papers) and Sarcoidosis and Beryllium Toxicity Research (25 papers). Imre Noth collaborates with scholars based in United States, United Kingdom and Germany. Imre Noth's co-authors include Mary E. Strek, Rekha Vij, Justin M. Oldham, Fernando J. Martínez, Alan R. Leff, Ayodeji Adegunsoye, Kevin J. Anstrom, Shwu‐Fan Ma, Harold R. Collard and Joyce Lee and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Imre Noth

138 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features

2015 655 citations Tamera J. Corte, Imre Noth et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imre Noth United States	41	5.3k	2.0k	937	909	757	143	6.1k
Mary E. Strek United States	40	4.4k 0.8×	1.9k 1.0×	1.3k 1.4×	1.0k 1.1×	777 1.0×	124	5.5k
Brett M. Elicker United States	38	5.0k 0.9×	2.0k 1.0×	802 0.9×	880 1.0×	554 0.7×	102	6.5k
Jeffrey J. Swigris United States	39	6.6k 1.3×	2.5k 1.3×	1.5k 1.6×	1.1k 1.2×	1.2k 1.6×	103	7.7k
Wim Wuyts Belgium	39	4.1k 0.8×	1.6k 0.8×	642 0.7×	493 0.5×	412 0.5×	199	5.3k
Sonoko Nagai Japan	38	4.3k 0.8×	2.0k 1.0×	1.4k 1.5×	527 0.6×	787 1.0×	117	5.8k
Yutaro Nakamura Japan	40	3.3k 0.6×	1.4k 0.7×	1.4k 1.4×	528 0.6×	787 1.0×	206	5.0k
Noriyuki Enomoto Japan	35	3.0k 0.6×	1.3k 0.6×	1.3k 1.4×	484 0.5×	799 1.1×	237	4.4k
Francesco Bonella Germany	41	3.9k 0.7×	1.3k 0.7×	576 0.6×	360 0.4×	422 0.6×	212	4.5k
Tomoyuki Fujisawa Japan	37	3.1k 0.6×	1.3k 0.7×	1.4k 1.4×	476 0.5×	735 1.0×	222	4.7k
Brett Ley United States	28	4.7k 0.9×	1.8k 0.9×	512 0.5×	420 0.5×	421 0.6×	48	5.1k

Countries citing papers authored by Imre Noth

Since Specialization

Citations

This map shows the geographic impact of Imre Noth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imre Noth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imre Noth more than expected).

Fields of papers citing papers by Imre Noth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imre Noth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imre Noth. The network helps show where Imre Noth may publish in the future.

Co-authorship network of co-authors of Imre Noth

This figure shows the co-authorship network connecting the top 25 collaborators of Imre Noth. A scholar is included among the top collaborators of Imre Noth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imre Noth. Imre Noth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alqalyoobi, Shehabaldin, Jennifer A. Smith, Manoj V. Maddali, et al.. (2025). Proteomic Biomarkers of Survival in Non–Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 211(8). 1452–1462.

Maher, Toby M., Gísli Jenkins, Vincent Cottin, et al.. (2024). Circulating biomarkers and progression of idiopathic pulmonary fibrosis: data from the INMARK trial. ERJ Open Research. 10(4). 335–2023. 3 indexed citations

Upadhyay, Vaibhav, Sara E. Vazquez, Cathryn T. Lee, et al.. (2024). Phage Immunoprecipitation‐Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease. ACR Open Rheumatology. 6(9). 568–580. 2 indexed citations

Pugashetti, Janelle Vu, J. Kim, Swaraj Bose, et al.. (2024). Biological Age, Chronological Age, and Survival in Pulmonary Fibrosis: A Causal Mediation Analysis. A1006–A1006.

Behr, Jürgen, Margaret L. Salisbury, Simon Walsh, et al.. (2024). The Role of Inflammation and Fibrosis in Interstitial Lung Disease Treatment Decisions. American Journal of Respiratory and Critical Care Medicine. 210(4). 392–400. 11 indexed citations

Kim, John, Shwu‐Fan Ma, Catherine A. Bonham, et al.. (2023). ASSOCIATIONS OF PLASMA OMEGA-3 FATTY ACIDS WITH PROGRESSION AND SURVIVAL IN PULMONARY FIBROSIS. CHEST Journal. 164(4). A3047–A3049. 1 indexed citations

Reynolds, Carl, Fabiola Del Greco M, Richard J. Allen, et al.. (2023). The causal relationship between gastro-oesophageal reflux disease and idiopathic pulmonary fibrosis: a bidirectional two-sample Mendelian randomisation study. European Respiratory Journal. 61(5). 2201585–2201585. 32 indexed citations

Kim, John S., Sydney B. Montesi, Ayodeji Adegunsoye, et al.. (2023). Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Annals of the American Thoracic Society. 20(12). 1683–1693. 1 indexed citations

Hoke, Tracey R., et al.. (2023). The Intensive Care Unit Bundle Board: A Novel Real-Time Data Visualization Tool to Improve Maintenance Care for Invasive Catheters. Applied Clinical Informatics. 14(5). 892–902. 1 indexed citations

10.

Huang, Yong, Shwu‐Fan Ma, Catherine A. Bonham, et al.. (2023). Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. BMJ Open Respiratory Research. 10(1). e001391–e001391. 9 indexed citations

11.

Kim, John S., Susan Murray, Eric Yow, et al.. (2023). Comparison of Pirfenidone and Nintedanib. CHEST Journal. 165(5). 1163–1173. 11 indexed citations

12.

Geng, Yan, Lin Li, Jie Yan, et al.. (2022). PEAR1 regulates expansion of activated fibroblasts and deposition of extracellular matrix in pulmonary fibrosis. Nature Communications. 13(1). 7114–7114. 34 indexed citations

13.

Sun, Jiehuan, Tong Zhang, Bing Xu, et al.. (2021). 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study. EBioMedicine. 69. 103439–103439. 15 indexed citations

14.

Ley, Brett, Dara G. Torgerson, Justin M. Oldham, et al.. (2019). Rare Protein-Altering Telomere-related Gene Variants in Patients with Chronic Hypersensitivity Pneumonitis. American Journal of Respiratory and Critical Care Medicine. 200(9). 1154–1163. 76 indexed citations

15.

Huang, Yong, Shwu‐Fan Ma, Milena S. Espíndola, et al.. (2017). Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 196(2). 208–219. 95 indexed citations

16.

Oldham, Justin M., Shwu‐Fan Ma, Fernando J. Martínez, et al.. (2015). TOLLIP , MUC5B , and the Response to N -Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 192(12). 1475–1482. 218 indexed citations

17.

Herazo‐Maya, Jose D., Imre Noth, Steven R. Duncan, et al.. (2013). Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis. Science Translational Medicine. 5(205). 205ra136–205ra136. 194 indexed citations

18.

Wei, Rongrong, Chong Li, Yava Jones‐Hall, et al.. (2013). Association between MUC5B and TERT polymorphisms and different interstitial lung disease phenotypes. Translational research. 163(5). 494–502. 51 indexed citations

19.

Noth, Imre & Mitchell A. Olman. (2012). Reply: Is Warfarin the Right Anticoagulant in Idiopathic Pulmonary Fibrosis?. American Journal of Respiratory and Critical Care Medicine. 186(7). 693–694. 1 indexed citations

20.

Noth, Imre, Kevin J. Anstrom, Sara B. Calvert, et al.. (2012). A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(1). 88–95. 317 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact